Japanese Journal of Clinical Oncology 30:295-300 (2000)
© 2000 Foundation for Promotion of Cancer Research
Heterogeneous Response Patterns of Alveolar Macrophages from Patients with Lung Cancer by Stimulation with Interferon-
1Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Kitakyushu and 2Department of Immunology, Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812, Japan
Background: Macrophages are considered to play an important role in the host defense against malignant tumors. In this study, cytotoxic activity of alveolar macrophages (AM) derived from 32 patients with lung cancer was investigated.
Methods: AM were aseptically obtained by lavage from resected lung and subsequently tested for cytolytic activity against QG56, a lung squamous cell line, following treatment with recombinant interferon-
(IFN-).
Results: In seven patients (21.9%), AM showed no cytotoxicity even though AM were incubated with IFN-. In 20 (62.5%), AM showed substantial cytotoxicity in response to IFN- in a dose-dependent manner. In the other five (15.6%), relatively strong cytotoxicity was observed even without preincubation with IFN-. Such a heterogeneous profile of the cytotoxicity of AM might be a reflection of various activated states of AM since the potential of cytotoxicity and that of IL-1 secretion were almost parallel. Both IFN- dependent and -independent cytotoxicity were partially blocked either by anti-tumor necrosis factor-
(TNF-) antibody or by the inhibitor of nitric oxide synthesis. However, those activities were completely abrogated by both treatments. Since the supernatant of AM culture exhibited TNF--mediated but not NO-mediated cytolysis, TNF- could mediate a bystander killing whereas NO acts in close contact with tumor cells.
Conclusion: The AM have anti-tumor cytotoxicity in lung cancer although the cytolytic potential is heterogeneous and that the tumor lysis by AM is mediated by both TNF- and NO production.
+ For reprints and all correspondence: Ryozo Eifuku, Department of Surgery II, School of Medicine, University of Occupational and Environmental Health, Iseigaoka 1–1, Yahatanishi-ku, Kitakyushu 807-8555, Japan Abbreviations: AM, alveolar macrophage; IFN-, interferon-; TNF-; tumor necrosis factor ; LPS, lipopolysacharide; NMM-L-A, N-monomethyl-L-arginine; NMM-D-A, N-monomethyl-D-arginine; ELISA, enzyme-linked immunosorbent assay; IL-1ß, interleukin 1ß; IL-12, interleukin 12; NO, nitric oxide; CM, culture medium
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-P. Herbeuval, C. Lambert, O. Sabido, M. Cottier, P. Fournel, M. Dy, and C. Genin Macrophages From Cancer Patients: Analysis of TRAIL, TRAIL Receptors, and Colon Tumor Cell Apoptosis J Natl Cancer Inst, April 16, 2003; 95(8): 611 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hickman-Davis, F. C. Fang, C. Nathan, V. L. Shepherd, D. R. Voelker, and J. R. Wright Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L517 - L523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hickman-Davis, P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon Killing of Klebsiella pneumoniae by human alveolar macrophages Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L944 - L956. [Abstract] [Full Text] [PDF]
|
|